Myeloid antigen co-expression in childhood acute lymphoblastic leukaemia: relationship with in vitro drug resistance

Keyphrases

• Acute Lymphoblastic Leukemia 100%
• Co-expression 100%
• Childhood Acute Lymphoblastic Leukemia 100%
• In Vitro Resistance 100%
• Myeloid Antigen 100%
• Daunorubicin 30%
• P-glycoprotein (P-gp) 30%
• Multidrug Resistance Protein 30%
• Lung Resistance Protein 30%
• L-asparaginase 20%
• Prognostic Value 20%
• Ifosfamide 20%
• Cytarabine 20%
• Drug Resistance 20%
• Mitoxantrone 20%
• Anthracyclines 10%
• Thiopurines 10%
• Initial Diagnosis 10%
• Treatment Regimen 10%
• Doxorubicin 10%
• Etoposide 10%
• Flow Cytometry 10%
• Acute Lymphoblastic Leukemia Cells 10%
• Idarubicin 10%
• Prednisolone 10%
• In Vitro Cytotoxicity 10%
• CD33 10%
• Cell Ratio 10%
• Contradictory Data 10%
• Methyl 10%
• 6-mercaptopurine (6-MP) 10%
• Drug Dosage 10%
• Leukemia children 10%
• Epipodophyllotoxin 10%
• Teniposide 10%
• Major Vault Protein 10%
• Thiazol 10%
• CD13 10%
• 6-thioguanine (6-TG) 10%
• Intensive Treatment 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Lymphoblastic Leukemia 100%
• Drug Resistance 100%
• Antigen 100%
• Lung Resistance Protein 28%
• Daunorubicin 21%
• P-Glycoprotein 21%
• Multidrug Resistance Associated Protein 21%
• Ifosfamide 14%
• Vincristine 14%
• Mercaptopurine 14%
• Cytarabine 14%
• Asparaginase 14%
• Mitoxantrone 14%
• Anthracycline 7%
• Etoposide 7%
• Doxorubicin 7%
• Dexamethasone 7%
• Tioguanine 7%
• Flow Cytometry 7%
• Glucocorticoid 7%
• Prednisolone 7%
• Drug Dose 7%
• Teniposide 7%
• Alanine Aminopeptidase 7%
• Epipodophyllotoxin 7%
• Idarubicin 7%
• Cytotoxicity 7%